As an obstacle to pregnancy, recurrent spontaneous abortion (RSA) can be caused by a variety of factors, and a current understanding of the etiology of RSA is still lacking; half of cases have an unknown cause. A substantial fraction of patients show no improvement after treatment.
Introduction Endometrial thickness is an important parameter to evaluate endometrial receptivity. An appropriate endometrial thickness is necessary for both embryo implantation and maintaining normal pregnancy. Women with thin endometrium are one of the critical challenges in the clinic, and current therapeutic strategies for thin endometrium remain suboptimal. The stromal vascular fraction (SVF) derived from adipose tissue contains a variety of cells, mainly adipose-derived stem/stromal cells and adipose cells. Recently, adipose tissue-derived SVF showed tremendous potential for treating thin endometrium due to its capacity to repair and regenerate tissues. The application of SVF in animal models for treating thin endometrium has been investigated. However, limited evidence has demonstrated the efficacy and safety of autologous SVF in patients with thin endometrium. Methods and analysis This study is a single-centre, longitudinal, prospective self-control study to investigate the preliminary efficacy and safety of autologous SVF in improving the pregnancy outcome of infertile patients with thin endometrium. Thirty patients diagnosed with thin endometrium will be recruited based on the inclusion and exclusion criteria. The SVF suspension will be transferred into the uterine cavity via an embryo transfer catheter. Then, comparisons between pretreatment and post-treatment will be analysed, and the outcomes, including endometrial thickness, menstrual volume and duration, frequency and severity of adverse events and early pregnancy outcomes, will be measured within a 3-month follow-up, while late pregnancy outcomes and their offspring will be followed up via telephone for 2 years. The proportion of patients with improved symptoms will be calculated and compared. Ethics and dissemination This study was approved by the Ethics Committee of Peking University Third Hospital (reference number: REC2020-165). Written informed consent will be provided for patients before being included. The results will be presented at academic conferences and a peer-reviewed journal. Trial registration number ChiCTR2000035126.
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, yet its etiopathogenesis remains poorly understood. There is ongoing debate regarding the diagnostic criteria for PCOS, with various clinical biomarkers proposed but none achieving widespread acceptance. This study investigated anogenital distance (AGD) and its relationship with microbiota in women with PCOS. Significant differences in AGD were observed between PCOS patients and a control group, with notable variations in anal microbiota. Specifically, relative abundances of Faecalibacterium and Gardnerella differed significantly between the two groups. The clinical pregnancy rate per embryo transfer was higher in the control group, indicating potentially poorer reproductive outcomes in the PCOS group. AGD metrics (AGD_ AC and AGD_ AF ) were identified as predictors of clinical pregnancy outcomes, with optimal cutoff values of 87.2 mm and 26.7 mm, respectively. These results provide initial evidence that AGD and microbiota may play roles in reproductive health in PCOS, warranting further research to validate these associations and explore their implications for treatment and prevention strategies in affected individuals.